Meta-analysis of FEV1 as a risk factor for all-cause mortality Source: Eur Respir J 2003; 22: Suppl. 45, 484s Year: 2003
No impact of statins on time to first COPD exacerbation or all-cause mortality Source: Virtual Congress 2021 – Inhaled treatments for COPD: real-world data Year: 2021
Desmosine is a predictor of long-term cardiovascular mortality in bronchiectasis Source: Virtual Congress 2020 – New biomarkers for management of obstructive diseases Year: 2020
Risk factors for all-cause mortality in patients with COPD: results from the ETHOS trial Source: Virtual Congress 2021 – Inhaled treatments for COPD: clinical trials and real-world studies Year: 2021
Predictors of mortality in COPD Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects Year: 2008
Predictors of mortality in COPD Source: Annual Congress 2009 - Prognosis and comorbidities in COPD Year: 2009
Age cohort mortality differences for respiratory and cardiovascular causes of death Source: Eur Respir J 2001; 18: Suppl. 33, 151s Year: 2001
Association of symptom subtypes and obstructive sleep apnoea-specific hypoxic burden with cardiovascular morbidity and all-cause mortality Source: Virtual Congress 2021 – From phenotyping to different diagnostic tools for sleep breathing disorders Year: 2021
COPD the unseen factor causing increased morbidity and mortality among IHD patients Source: Annual Congress 2009 - COPD case-finding and management in primary care Year: 2009
Level of FEV1 as a predictor of all-cause and cardiovascular mortality: an effect beyond smoking and physical fitness? Source: Eur Respir J 2005; 25: 587-588 Year: 2005
Changes in physical activity and all-cause mortality in COPD Source: Eur Respir J 2014; 44: 1199-1209 Year: 2014
Impact of intermittent hypoxia on cardiovascular morbidity and mortality Source: Research Seminar 2005 - Adaptations to Hypoxia Year: 2005
Accelerated FEV1 decline and risk of cardiovascular disease and mortality in a primary care population of COPD patients Source: Eur Respir J, 57 (3) 2000918; 10.1183/13993003.00918-2020 Year: 2021
Association between lung function and future risks of diabetes, asthma, myocardial infarction, hypertension and all-cause mortality Source: ERJ Open Res, 7 (3) 00178-2021; 10.1183/23120541.00178-2021 Year: 2021
Inhaled corticosteroid therapy reduces the risk of rehospitalization and all-cause mortality in elderly asthmatics Source: Eur Respir J 2001; 17: 380-385 Year: 2001
hsCRP is associated with 10-year mortality in COPD. Source: Virtual Congress 2020 – Mechanism or pathways of chronic lung diseases Year: 2020
The impact on risk-factor analysis of different mortality outcomes in COPD patients Source: Eur Respir J 2008; 32: 629-636 Year: 2008
CPAP can decrease fatal and non-fatal cardiovascular events in OSAH Source: ISSN=ISSN 1810-6838, ISBN=, page=266 Year: 2006
Glitazones are associated with reduced risk of COPD exacerbations and mortality among patients with diabetes Source: Annual Congress 2011 - COPD: burden of disease, imaging and management Year: 2011
Exacerbations and mortality of COPD patients with cardiovascular disease in the UK Source: Annual Congress 2010 - Comorbidity in obstructive airway disease Year: 2010